Sanofi
- SEC CIK
- 0001121404
In the past year, 1 open-market purchase filing worth $5.10M and no sales.
Current role at each company
- LTGO Latigo Biotherapeutics, Inc.10% Owneras of Aug 12, 2026
- ATTO Attovia Therapeutics, Inc.10% Owneras of Aug 7, 2026
- Translate Bio, Inc.10% Owneras of Sep 14, 2021
- ICVX Icosavax, Inc.10% Owneras of Aug 2, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $5.10M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$5.10M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sanofi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATTO Attovia Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 (view filing)3:45 PM ET | Aug 6 | 1 day | Sanofi10% Owner | PPurchase | +300.0K | $17.00 | +$5.10M | +38.3%1.08M after |
Translate Bio, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Sanofi10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +72.0M | $38.00 | +$2.74B | +1,953.7%75.7M after | 2 lots |
ICVX Icosavax, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 (view filing) | Aug 2 | Same day | Sanofi10% Owner | PPurchaseCommon Stock (par value, $0.0001) | +66.7K | $15.00 | +$1.00M | +2.2%3.16M after |